Concepedia

Michael Hetmann

MH

6

Publications

171

Citations

6

H-Index

2019

Active since

Affiliations

Austrian Centre of Industrial Biotechnology (Austria)(Current)

University of Graz

Nvidia (United States)

Michael Hetmann is an author at Austrian Centre of Industrial Biotechnology (Austria) specializing in drug development, small molecules, and drug discovery.

ORCID

Top concepts

Publications per year

2019–2024

6

Publications

6

Chemoenzymatic Total Synthesis of Deoxy‐, <i>epi</i>‐, and Podophyllotoxin and a Biocatalytic Kinetic Resolution of Dibenzylbutyrolactones

Mattia Lazzarotto, Lucas Hammerer, Michael Hetmann et al. · Angewandte Chemie International Edition · 2019 · 81 citations · Full text

Identification and validation of fusidic acid and flufenamic acid as inhibitors of SARS-CoV-2 replication using DrugSolver CavitomiX

Michael Hetmann, Christine Langner, Vedat Durmaz et al. · Scientific Reports · 2023 · 27 citations · Full text

Structural bioinformatics analysis of SARS-CoV-2 variants reveals higher hACE2 receptor binding affinity for Omicron B.1.1.529 spike RBD compared to wild type reference

Vedat Durmaz, Katharina Köchl, A. Krassnigg et al. · Scientific Reports · 2022 · 24 citations · Full text

A community effort in SARS‐CoV‐2 drug discovery

Johannes Schimunek, Philipp Seidl, Katarina Elez et al. · Molecular Informatics · 2023 · 17 citations · Full text

, , +13

Recent changes in the mutational dynamics of the SARS-CoV-2 main protease substantiate the danger of emerging resistance to antiviral drugs

Lena Parigger, A. Krassnigg, Tobias Schopper et al. · Frontiers in Medicine · 2022 · 12 citations · Full text

Rows per page

1–5 of 6